z-logo
Premium
Iron(III) Complexation by New Aminocarboxylate Chelators − Thermodynamic and Kinetic Studies
Author(s) -
Serratrice Guy,
Galey JeanBaptiste,
Aman Eric Saint,
Dumats Jacqueline
Publication year - 2001
Publication title -
european journal of inorganic chemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.667
H-Index - 136
eISSN - 1099-0682
pISSN - 1434-1948
DOI - 10.1002/1099-0682(200102)2001:2<471::aid-ejic471>3.0.co;2-a
Subject(s) - chemistry , ethylenediamine , potentiometric titration , ferric , ligand (biochemistry) , redox , aqueous solution , chelation , kinetics , inorganic chemistry , medicinal chemistry , reaction rate constant , dissociation (chemistry) , stereochemistry , organic chemistry , ion , biochemistry , physics , receptor , quantum mechanics
The complexation of Fe III by new tetradentate and pentadentate aminocarboxylate chelators, designed to protect cells against iron‐catalysed oxidative damage, was investigated. Ferric iron complexes of N , N′ ‐bis(3,4,5‐trimethoxybenzyl)ethylenediamine‐ N , N′ ‐diacetic acid ( L1 ), N , N′ ‐dibenzylethylenediamine‐ N , N′ ‐diacetic acid ( L2 ) and [ N ‐(2‐hydroxybenzyl)‐ N′ ‐benzylethylenediamine‐ N , N′ ‐diacetic acid] ( L3 ) have been characterized in aqueous solution by potentiometric, UV/Vis spectrophotometric and cyclic voltammetric measurements. The parent ligand, ethylenediamine‐ N , N′ ‐diacetic acid ( L4 ), has also been studied. As expected, the presence of a hard phenolate donor group in L3 significantly enhances the affinity for iron while decreasing the potential of the Fe III /Fe II redox couple compared to L1 or L2 . Kinetics studies have provided the kinetic rate constants related to the formation and the dissociation of the ferric complex with L3 . The results reveal a fast Fe III uptake, which is a favorable feature for a biological use of this type of ligand. Overall, these results demonstrate the pertinence of the use of such ligands to protect biological tissues against oxidative stress.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here